688016 心脉医疗
已收盘 03-27 15:00:00
资讯
新帖
简况
每周股票复盘:心脉医疗(688016)获可解脱带纤维毛栓塞弹簧圈注册证
证券之星 · 03-15
每周股票复盘:心脉医疗(688016)获可解脱带纤维毛栓塞弹簧圈注册证
心脉医疗(688016.SH):可解脱带纤维毛栓塞弹簧圈获得医疗器械注册证
智通财经 · 03-13
心脉医疗(688016.SH):可解脱带纤维毛栓塞弹簧圈获得医疗器械注册证
3月10日心脉医疗涨5.41%,新华战略新兴产业灵活配置混合基金重仓该股
证券之星 · 03-10
3月10日心脉医疗涨5.41%,新华战略新兴产业灵活配置混合基金重仓该股
心脉医疗涨5.41%,国金证券一周前给出“买入”评级
证券之星 · 03-10
心脉医疗涨5.41%,国金证券一周前给出“买入”评级
港股异动 | 微创医疗(00853)涨超5% 心脉医疗年度归母净利同比增长12.17% 公司在研产品稳步推进
智通财经 · 03-05
港股异动 | 微创医疗(00853)涨超5% 心脉医疗年度归母净利同比增长12.17% 公司在研产品稳步推进
3月2日心脉医疗涨10.15%,新华战略新兴产业灵活配置混合基金重仓该股
证券之星 · 03-02
3月2日心脉医疗涨10.15%,新华战略新兴产业灵活配置混合基金重仓该股
心脉医疗涨10.15%,国金证券一日前给出“买入”评级
证券之星 · 03-02
心脉医疗涨10.15%,国金证券一日前给出“买入”评级
每周股票复盘:心脉医疗(688016)2025年净利增12.17%
证券之星 · 03-01
每周股票复盘:心脉医疗(688016)2025年净利增12.17%
心脉医疗(688016)披露2025年年度业绩快报公告,2月27日股价下跌0.12%
证券之星 · 02-27
心脉医疗(688016)披露2025年年度业绩快报公告,2月27日股价下跌0.12%
微创医疗(00853):心脉医疗 (688016.SH)2025年归母净利约5.63亿元,同比增长12.17%
智通财经 · 02-27
微创医疗(00853):心脉医疗 (688016.SH)2025年归母净利约5.63亿元,同比增长12.17%
微创科学:心脉医疗全年归属股东净利润达5.632亿元人民币
美股速递 · 02-27
微创科学:心脉医疗全年归属股东净利润达5.632亿元人民币
心脉医疗(688016.SH)子公司获得医疗器械注册证
智通财经 · 02-04
心脉医疗(688016.SH)子公司获得医疗器械注册证
每周股票复盘:心脉医疗(688016)拟用10亿闲置募资做现金管理
证券之星 · 01-25
每周股票复盘:心脉医疗(688016)拟用10亿闲置募资做现金管理
心脉医疗(688016)披露使用部分暂时闲置募集资金进行现金管理,1月19日股价下跌1.28%
证券之星 · 01-19
心脉医疗(688016)披露使用部分暂时闲置募集资金进行现金管理,1月19日股价下跌1.28%
中邮证券:给予心脉医疗买入评级
证券之星 · 01-07
中邮证券:给予心脉医疗买入评级
每周股票复盘:心脉医疗(688016)选举新任非独立董事
证券之星 · 01-02
每周股票复盘:心脉医疗(688016)选举新任非独立董事
心脉医疗(688016)公司公告选举第三届董事会非独立董事,12月31日股价上涨0.07%
证券之星 · 2025-12-31
心脉医疗(688016)公司公告选举第三届董事会非独立董事,12月31日股价上涨0.07%
心脉医疗(688016)披露董事长及董事辞职并提名新任非独立董事候选人,12月18日股价下跌0.05%
证券之星 · 2025-12-18
心脉医疗(688016)披露董事长及董事辞职并提名新任非独立董事候选人,12月18日股价下跌0.05%
心脉医疗(688016)披露关于召开2025年第二次临时股东会的通知,12月15日股价下跌0.33%
证券之星 · 2025-12-15
心脉医疗(688016)披露关于召开2025年第二次临时股东会的通知,12月15日股价下跌0.33%
每周股票复盘:心脉医疗(688016)现折价18.73%大宗交易
证券之星 · 2025-11-23
每周股票复盘:心脉医疗(688016)现折价18.73%大宗交易
加载更多
公司概况
公司名称:
上海微创心脉医疗科技(集团)股份有限公司
所属行业:
专用设备制造业
上市日期:
2019-07-22
主营业务:
上海微创心脉医疗科技(集团)股份有限公司的主营业务是主动脉及外周血管介入医疗器械的研发、生产、销售和服务。公司的主要产品是胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司荣获“2024年度浦东新区先进制造业突出贡献奖”,公司核心产品Castor®分支型主动脉覆膜支架的专利技术正式获得第二十五届中国专利金奖。此外,Vflower®静脉支架系统等多个产品入选2025年度上海市生物医药创新产品攻关项目及浦东新区生物医药产业高质量发展专项支持。
发行价格:
46.23
{"stockData":{"symbol":"688016","market":"SH","secType":"STK","nameCN":"心脉医疗","latestPrice":104.58,"timestamp":1774594800000,"preClose":102.65,"halted":0,"volume":1966083,"delay":0,"changeRate":0.0188,"floatShares":123000000,"shares":123000000,"eps":3.0652,"marketStatus":"已收盘","change":1.93,"latestTime":"03-27 15:00:00","open":101.6,"high":105.58,"low":101.6,"amount":205000000,"amplitude":0.0388,"askPrice":104.58,"askSize":27,"bidPrice":104.57,"bidSize":6,"shortable":0,"etf":0,"ttmEps":3.0652,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":5,"adr":0,"adjPreClose":102.65,"symbolType":"stock_kcb","openAndCloseTimeList":[[1774575000000,1774582200000],[1774587600000,1774594800000]],"highLimit":112.92,"lowLimit":92.39,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":123262117,"isCdr":false,"pbRate":3.26,"roa":"--","peRate":34.118491,"roe":"10.95%","epsLYR":4.07,"committee":-0.531034,"marketValue":12891000000,"turnoverRate":0.016,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-03-30。","afterMarket":{"amount":0,"volume":0,"close":104.58,"buyVolume":0,"sellVolume":0,"time":1774596837558,"indexStatus":"已收盘 03-27 15:30:00","preClose":102.65},"floatMarketCap":12891000000},"requestUrl":"/m/hq/s/688016","defaultTab":"news","newsList":[{"id":"2619120649","title":"每周股票复盘:心脉医疗(688016)获可解脱带纤维毛栓塞弹簧圈注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2619120649","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619120649?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:06","pubTimestamp":1773511573,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘,心脉医疗报收于107.25元,较上周的107.38元下跌0.12%。本周,心脉医疗3月11日盘中最高价报112.95元。本周关注点来自公司公告汇总:获可解脱带纤维毛栓塞弹簧圈注册证公司公告汇总心脉医疗:关于获得医疗器械注册证的自愿性披露公告近日,上海微创心脉医疗科技(集团)股份有限公司控股子公司上海鸿脉医疗科技有限公司获得国家药品监督管理局颁发的关于可解脱带纤维毛栓塞弹簧圈的医疗器械注册证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2619852193","title":"心脉医疗(688016.SH):可解脱带纤维毛栓塞弹簧圈获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2619852193","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619852193?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:48","pubTimestamp":1773395289,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心脉医疗(688016.SH)发布公告,近日,公司控股子公司上海鸿脉医疗科技有限公司获得国家药品监督管理局颁发的关于可解脱带纤维毛栓塞弹簧圈的医疗器械注册证。HawkMaster™/龙鸢™可解脱带纤维毛栓塞弹簧圈是公司继HawkNest™/鹰巢™带纤维毛栓塞弹簧圈之后获批上市的第二款弹簧圈栓塞类产品。该产品的上市进一步丰富了公司在外周动脉领域的产品组合,也进一步完善了公司在外周血管介入治疗领域的产品布局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","09996","688016","BK1222","09997","BK1583","159883","BK1574","BK1100"],"gpt_icon":0},{"id":"2618980519","title":"3月10日心脉医疗涨5.41%,新华战略新兴产业灵活配置混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618980519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618980519?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:19","pubTimestamp":1773130768,"startTime":"0","endTime":"0","summary":"证券之星消息,3月10日心脉医疗涨5.41%,收盘报109.95元,换手率2.64%,成交量3.26万手,成交额3.54亿元。重仓心脉医疗的公募基金请见下表:该股最近90天内共有3家机构给出评级,买入评级3家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为新华基金的新华战略新兴产业灵活配置混合。新华战略新兴产业灵活配置混合目前规模为0.53亿元,最新净值0.9581,较上一交易日上涨1.23%,近一年上涨10.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000024220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2618980650","title":"心脉医疗涨5.41%,国金证券一周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2618980650","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618980650?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:19","pubTimestamp":1773130759,"startTime":"0","endTime":"0","summary":"今日心脉医疗涨5.41%,收盘报109.95元。2026年3月1日,国金证券研究员甘坛焕,何冠洲发布了对心脉医疗的研报《全年业绩稳定增长,创新研发持续推进》,该研报对心脉医疗给出“买入”评级。研报中预计公司2025-2027年归母净利润分别为5.63、7.01、8.62亿元,同比+12%、+24%、+23%,现价对应PE为22、18、15倍,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为方正证券的周小刚。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000024218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016"],"gpt_icon":0},{"id":"2617331594","title":"港股异动 | 微创医疗(00853)涨超5% 心脉医疗年度归母净利同比增长12.17% 公司在研产品稳步推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2617331594","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617331594?lang=zh_cn&edition=full","pubTime":"2026-03-05 11:44","pubTimestamp":1772682266,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,微创医疗涨超5%,截至发稿,涨5.19%,报1.42港元,成交额1946.91万港元。消息面上,近日,微创医疗公布心脉医疗2025年年度业绩快报,营业总收入约13.51亿元,同比增长11.96%;归属于母公司所有者的净利润约5.63亿元,同比增长12.17%;基本每股收益4.65元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","VT","BK1100","00853","BK1585","BK4585","BK0251","BK1589","688016","VXUS","BK1583"],"gpt_icon":0},{"id":"2616381198","title":"3月2日心脉医疗涨10.15%,新华战略新兴产业灵活配置混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2616381198","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616381198?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440215,"startTime":"0","endTime":"0","summary":"证券之星消息,3月2日心脉医疗涨10.15%创60日新高,收盘报111.8元,换手率6.43%,成交量7.93万手,成交额8.73亿元。重仓心脉医疗的公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为新华基金的新华战略新兴产业灵活配置混合。新华战略新兴产业灵活配置混合目前规模为0.53亿元,最新净值1.0024,较上一交易日上涨1.61%,近一年上涨14.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200022614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2616154381","title":"心脉医疗涨10.15%,国金证券一日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2616154381","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616154381?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:29","pubTimestamp":1772440197,"startTime":"0","endTime":"0","summary":"今日心脉医疗涨10.15%,收盘报111.8元。2026年3月1日,国金证券研究员甘坛焕,何冠洲发布了对心脉医疗的研报《全年业绩稳定增长,创新研发持续推进》,该研报对心脉医疗给出“买入”评级。研报中预计公司2025-2027年归母净利润分别为5.63、7.01、8.62亿元,同比+12%、+24%、+23%,现价对应PE为22、18、15倍,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为方正证券的周小刚。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200022608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016"],"gpt_icon":0},{"id":"2616584393","title":"每周股票复盘:心脉医疗(688016)2025年净利增12.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616584393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616584393?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:02","pubTimestamp":1772301740,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,心脉医疗报收于101.5元,较上周的96.95元上涨4.69%。本周,心脉医疗2月25日盘中最高价报102.5元。本周关注点来自业绩披露要点:心脉医疗2025年归属净利润达5.632亿元,同比增长12.17%。公司公告汇总上海微创心脉医疗科技(集团)股份有限公司发布2025年年度业绩快报。基本每股收益4.65元,同比增长14.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2614885250","title":"心脉医疗(688016)披露2025年年度业绩快报公告,2月27日股价下跌0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614885250","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614885250?lang=zh_cn&edition=full","pubTime":"2026-02-27 22:42","pubTimestamp":1772203335,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,心脉医疗报收于101.5元,较前一交易日下跌0.12%,最新总市值为125.11亿元。该股当日开盘101.29元,最高101.6元,最低100.12元,成交额达9045.56万元,换手率为0.73%。近日,上海微创心脉医疗科技(集团)股份有限公司发布2025年年度业绩快报。报告期内,公司实现营业总收入13.51亿元,同比增长11.96%;归属于母公司所有者的净利润为5.63亿元,同比增长12.17%;扣除非经常性损益后的净利润为5.02亿元,同比增长26.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700042638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2614830422","title":"微创医疗(00853):心脉医疗 (688016.SH)2025年归母净利约5.63亿元,同比增长12.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614830422","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614830422?lang=zh_cn&edition=full","pubTime":"2026-02-27 19:56","pubTimestamp":1772193414,"startTime":"0","endTime":"0","summary":"智通财经APP讯,微创医疗 公布心脉医疗 2025 年年度业绩快报,营业总收入约13.51亿元,同比增长11.96%;归属于母公司所有者的净利润约5.63亿元,同比增长12.17%;基本每股收益4.65元。截至报告期末,公司产品销售覆盖 49 个国家和地区(含中国)。公司累计 23 款产品获得 NMPA 首次注册证,11 款产品在 28 个海外市场获得首次注册证;累计获得海外产品注册证 110 余张,其中 6 款产品获得 CE 认证,3 款产品获得欧盟定制证书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00853","BK1585","BK1583","BK0251","BK1100","688016","BK1589"],"gpt_icon":0},{"id":"1132771086","title":"微创科学:心脉医疗全年归属股东净利润达5.632亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1132771086","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132771086?lang=zh_cn&edition=full","pubTime":"2026-02-27 19:50","pubTimestamp":1772193028,"startTime":"0","endTime":"0","summary":"微创科学(Microport Scientific)近日发布业绩公告,其旗下核心企业——上海心脉医疗科技(集团)股份有限公司(Shanghai Microport Endovascular Medtech)在最新财年表现亮眼。根据披露数据,心脉医疗全年实现归属母公司股东的净利润为5.632亿元人民币。\n这一业绩凸显了心脉医疗在血管介入医疗器械领域的持续领先地位与稳健的盈利能力。作为微创科学的重要组成部分,心脉医疗的强劲表现也为集团整体发展注入了积极动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","00853","BK1585","BK0251","BK1589","688016","BK1583"],"gpt_icon":0},{"id":"2608359486","title":"心脉医疗(688016.SH)子公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2608359486","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608359486?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:47","pubTimestamp":1770194847,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心脉医疗(688016.SH)发布公告,近日,公司的全资子公司上海拓脉医疗科技有限公司(简称“拓脉医疗”)获得国家药品监督管理局颁发的关于聚乙烯醇栓塞微球的医疗器械注册证。该产品适用于富血管型实质性器官恶性肿瘤的栓塞治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1222","159883","688016","09997","BK0251","09996","BK1583","BK1100"],"gpt_icon":0},{"id":"2606823218","title":"每周股票复盘:心脉医疗(688016)拟用10亿闲置募资做现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2606823218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606823218?lang=zh_cn&edition=full","pubTime":"2026-01-25 02:44","pubTimestamp":1769280251,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,心脉医疗报收于98.1元,较上周的97.98元上涨0.12%。本周,心脉医疗1月23日盘中最高价报98.67元。该事项无需提交股东大会审议。中国国际金融股份有限公司关于上海微创心脉医疗科技(集团)股份有限公司使用部分暂时闲置募集资金进行现金管理事项的核查意见心脉医疗计划使用不超过人民币100,000万元的暂时闲置募集资金进行现金管理,投资安全性高、流动性好的产品,资金可滚动使用,期限为董事会审议通过之日起12个月内。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2604813125","title":"心脉医疗(688016)披露使用部分暂时闲置募集资金进行现金管理,1月19日股价下跌1.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604813125","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604813125?lang=zh_cn&edition=full","pubTime":"2026-01-19 22:46","pubTimestamp":1768833973,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘,心脉医疗报收于96.73元,较前一交易日下跌1.28%,最新总市值为119.23亿元。近日,心脉医疗发布关于使用部分暂时闲置募集资金进行现金管理的公告。公告显示,公司于2026年1月19日召开第三届董事会第十二次会议,审议通过使用不超过人民币100,000万元的暂时闲置募集资金进行现金管理,投资安全性高、流动性好的产品,包括结构性存款、通知存款、定期存款、大额存单、收益凭证等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900036044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2601829456","title":"中邮证券:给予心脉医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601829456","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601829456?lang=zh_cn&edition=full","pubTime":"2026-01-07 13:25","pubTimestamp":1767763517,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司盛丽华,陈峻近期对心脉医疗进行研究并发布了研究报告《公司三季度毛利率环比提升,海外业务增长强劲》,给予心脉医疗买入评级。Talos/通天眼直管型胸主动脉覆膜支架系CHINA统已在南美上市,并将获批CE认证;Hector胸主动脉多分支覆膜支架系统今年7月已在欧洲获得CMD批准。最新盈利预测明细如下:该股最近90天内共有7家机构给出评级,买入评级6家,增持评级1家;过去90天内机构目标均价为136.03。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700017189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688016"],"gpt_icon":0},{"id":"2600398860","title":"每周股票复盘:心脉医疗(688016)选举新任非独立董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2600398860","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600398860?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:43","pubTimestamp":1767296590,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,心脉医疗报收于93.43元,较上周的92.8元上涨0.68%。本周,心脉医疗12月26日盘中最高价报94.28元。本周关注点公司公告汇总:心脉医疗选举孙洪斌、梁敏、刘旭东为第三届董事会非独立董事,得票率均超99%。出席会议股东所持表决权占公司总表决权的42.6305%。北京市嘉源律师事务所对本次会议出具法律意见书,认为会议召集、召开程序、表决结果合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2595777673","title":"心脉医疗(688016)公司公告选举第三届董事会非独立董事,12月31日股价上涨0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595777673","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595777673?lang=zh_cn&edition=full","pubTime":"2025-12-31 22:25","pubTimestamp":1767191119,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,心脉医疗报收于91.66元,较前一交易日上涨0.07%,最新总市值为112.98亿元。该股当日开盘91.0元,最高91.99元,最低91.0元,成交额达7383.02万元,换手率为0.65%。近日,上海微创心脉医疗科技(集团)股份有限公司召开2025年第二次临时股东会,会议审议通过关于选举孙洪斌、梁敏、刘旭东为公司第三届董事会非独立董事的议案。公告显示,上述候选人得票率均超过99%,当选生效。出席会议股东所持表决权占公司总表决权的42.6305%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100044910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2592902264","title":"心脉医疗(688016)披露董事长及董事辞职并提名新任非独立董事候选人,12月18日股价下跌0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592902264","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592902264?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:40","pubTimestamp":1766068834,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘,心脉医疗报收于92.49元,较前一交易日下跌0.05%,最新总市值为114.01亿元。近日,心脉医疗发布公告称,公司董事会于2025年12月15日收到董事长Jonathan Chen先生和董事霍庆福先生的辞职报告,二人因个人原因辞去公司职务,辞职后不再担任公司任何职务。为保证董事会正常运作,董事会拟将董事人数由8名增至9名,并提名孙洪斌、梁敏、刘旭东为第三届董事会非独立董事候选人,任期至本届董事会任期届满。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800039234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"gpt_icon":0},{"id":"2591424836","title":"心脉医疗(688016)披露关于召开2025年第二次临时股东会的通知,12月15日股价下跌0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591424836","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591424836?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:30","pubTimestamp":1765809044,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘,心脉医疗报收于91.05元,较前一交易日下跌0.33%,最新总市值为112.23亿元。该股当日开盘90.88元,最高91.86元,最低90.8元,成交额达7160.64万元,换手率为0.64%。近日,心脉医疗发布公告称,公司将于2025年12月31日召开2025年第二次临时股东会,会议将采用现场投票与网络投票相结合的方式进行,网络投票通过上海证券交易所系统开展。股权登记日为2025年12月24日,A股股东可参与投票。会议对中小投资者单独计票,不涉及关联股东回避表决。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500036069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2585510516","title":"每周股票复盘:心脉医疗(688016)现折价18.73%大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2585510516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585510516?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:45","pubTimestamp":1763840714,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘,心脉医疗报收于91.25元,较上周的102.25元下跌10.76%。本周,心脉医疗11月17日盘中最高价报102.94元。11月21日盘中最低价报91.23元。心脉医疗当前最新总市值112.48亿元,在医疗器械板块市值排名31/126,在两市A股市值排名1611/5167。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774641742509,"stockEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0293},{"period":"3month","weight":0.1193},{"period":"6month","weight":-0.0287},{"period":"1year","weight":0.1353},{"period":"ytd","weight":0.141}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0563},{"period":"3month","weight":-0.0126},{"period":"6month","weight":0.0224},{"period":"1year","weight":0.1601},{"period":"ytd","weight":-0.0139}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海微创心脉医疗科技(集团)股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"15990人(较上一季度减少8.73%)","perCapita":"7708股","listingDate":"2019-07-22","address":"上海市浦东新区康新公路3399弄1号","registeredCapital":"12326万元","survey":" 上海微创心脉医疗科技(集团)股份有限公司的主营业务是主动脉及外周血管介入医疗器械的研发、生产、销售和服务。公司的主要产品是胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司荣获“2024年度浦东新区先进制造业突出贡献奖”,公司核心产品Castor®分支型主动脉覆膜支架的专利技术正式获得第二十五届中国专利金奖。此外,Vflower®静脉支架系统等多个产品入选2025年度上海市生物医药创新产品攻关项目及浦东新区生物医药产业高质量发展专项支持。","listedPrice":46.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心脉医疗,688016,心脉医疗股票,心脉医疗股票老虎,心脉医疗股票老虎国际,心脉医疗行情,心脉医疗股票行情,心脉医疗股价,心脉医疗股市,心脉医疗股票价格,心脉医疗股票交易,心脉医疗股票购买,心脉医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}